C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC

Pancreatic ductal adenocarcinoma (PDAC) is a dismal disease with a poor clinical prognosis and unsatisfactory treatment options. We previously found that the transcription factor CCAAT/Enhancer-Binding Protein Delta (C/EBPδ) is lowly expressed in PDAC compared to healthy pancreas duct cells, and tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartl, Leonie, Roelofs, Joris J. T. H., Dijk, Frederike, Bijlsma, Maarten F., Duitman, JanWillem, Spek, C. Arnold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867044/
https://www.ncbi.nlm.nih.gov/pubmed/36675048
http://dx.doi.org/10.3390/ijms24021537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867044/
https://www.ncbi.nlm.nih.gov/pubmed/36675048
http://dx.doi.org/10.3390/ijms24021537

Ejemplares similares